Developer docs
API playgroundTry for free, no card

Search company profiles

Siron Clinical

Full company profile

uuid002tb2c

Namestring
Siron Clinical
Legal namestring
Siron Clinical
Company typeenum
Private
Founded yearint
2000
Short descriptiontext

Siron Clinical is a Netherlands-based CRO specializing in complex clinical trials for orphan, pediatric, and medical device programs. It serves small and medium-sized biotech sponsors across Europe with customizable FSP and full-service models, and is now part of WEP Clinical following its January 2026 acquisition.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRoosendaal, Netherlands
HQ citystring
Roosendaal
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial services, contract research organization, regulatory submissions, clinical monitoring, orphan disease trials
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Health Services8000
Product category
Contract Research Organization (CRO) Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1CRO Services – FSP Engagements
TypeProfessional Services
Description

Siron Clinical provides specialized Functional Service Provider engagements where sponsors engage the company for specific tasks and functions (clinical monitoring, regulatory submissions, project management, data management) at every stage of clinical trials. Revenue is generated through service contracts with biotech and pharma sponsors.

sironclinical.com
2CRO Services – Full-Service Contracts
TypeProfessional Services
Description

Full-service CRO contracts providing end-to-end clinical trial management from Phase I through Phase IV, covering project management, clinical monitoring, quality assurance, regulatory submissions, and additional services for biotech companies navigating European clinical research.

sironclinical.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Siron Clinical is an international contract research organization (CRO) that provides clinical trial services to biotech and biopharma sponsors, including customizable Functional Service Provider (FSP) engagements and full-service CRO contracts. Core offerings cover project management, clinical monitoring, quality assurance and control, regulatory submissions, and additional services such as data management, with specialized expertise in orphan disease, pediatric, and medical device trials across Europe, Israel, and Turkey.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 120+ supported clinical studies over 25 years of operation
+2 more records
Product overview1 text field

Siron Clinical is an international contract research organization (CRO) offering a portfolio of clinical trial services ranging from Customizable Functional Service Provider (FSP) to full-service solutions. The core product offering includes six interconnected service modules: Customizable FSP (providing flexible specialist expertise), Project Management, Clinical Monitoring, Quality Assurance and Control, Regulatory Submissions, and Additional Services (including data management). The company specializes in complex clinical trials across orphan diseases, pediatric research, and medical device sectors, supporting biotech companies through Phase I-IV trial delivery across Europe and the Middle East.

Product and service6 records
1Customizable Functional Service Provider (FSP)
CategoryClinical Trial Services
Description

Flexible outsourcing model providing specialist expertise and fulfilling specific tasks and functions at every stage of clinical trials, allowing biotech sponsors to scale support as needed across functions such as clinical monitoring, regulatory submissions, and project management.

2Project Management
CategoryClinical Trial Services
Description

Clinical trial project management and leadership services providing flexibility, innovation, and integrity for successful trial execution for biotech sponsors.

3Clinical Monitoring
CategoryClinical Trial Services
Description

Expert monitoring support for investigators and study teams providing strategic knowledge, specific guidance, and expertise for study execution across multiple therapeutic areas, delivered by Siron's senior CRAs.

4Quality Assurance and Control
CategoryClinical Trial Services
Description

Quality assurance and quality control services ensuring accuracy and integrity through continual and dynamic quality processes across clinical trial operations.

5Regulatory Submissions
CategoryClinical Trial Services
Description

Regulatory submission services with central management of submission processes, handling global regulatory requirements—including the EU Clinical Trials Regulation and CTIS—efficiently and effectively.

6Additional Services (Data Management and Partnerships)
CategoryClinical Trial Services
Description

Additional CRO services including clinical data management and industry partnerships for international and regional clinical research support.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

WEP Clinical, a US-based full-service CRO headquartered in Morrisville, North Carolina, acquired Siron Clinical in January 2026. The acquisition integrates Siron's expertise in orphan diseases, pediatric research, and medical device trials—backed by over 120 supported studies—into WEP's global operations, expanding its Phase I–IV trial delivery capabilities across Europe and the Middle East. Siron continues operating from its current locations in the Netherlands, Belgium, and Germany as part of WEP's Clinical Trials division.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2020-03-01
Description

Siron Clinical partnered with Montrium in March 2020 to provide clients with access to cutting-edge electronic Trial Master File (eTMF) technology. The partnership enables efficient and effective trial documentation management, improved regulatory compliance, and greater inspection readiness. Montrium is an eTMF provider at the forefront of providing electronic solutions to small and medium-sized companies, offering features including document storage, multi-user access, collaboration tools, and version management.

Strategic tierSupportingTypeImplementation/ SI/ Consulting Partner
Description

Siron Clinical partnered with Seuss+, a life-science management consulting company, for its 2020 rebranding from 'Siron' to 'Siron Clinical'. Seuss+ led the brand discovery and creative process, including workshops, visual rebranding, and development of the company's new mission, vision, and values. The rebranding resulted in a new green logo (symbolizing renewal, energy, growth, harmony, and safety) and a modern visual identity reflecting Siron Clinical's DNA.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

ICON is a top-3 global CRO offering full-service and FSP engagements across all therapeutic areas and geographies. Broad incumbent competing with Siron for biotech sponsors seeking full-service or large-FSP partnerships.

TypeDirect peer
Description

Worldwide Clinical Trials is a mid-size CRO offering full-service and FSP engagements across multiple therapeutic areas. Comparable to Siron in mid-tier CRO positioning, biotech sponsor focus, and FSP/full-service dual offering.

TypeDirect peer
Description

Premier Research is a mid-size CRO with explicit specialization in rare disease, oncology, and pediatric trials. Highly comparable to Siron in niche therapeutic focus and biotech sponsor base.

TypeDirect peer
Description

PSI is a privately held mid-size CRO with strong European roots serving biotech and pharma sponsors across all phases. Comparable to Siron in CRO scale tier, biotech customer focus, and full-service clinical operations.

TypeBroad incumbent
Description

IQVIA is the largest global CRO offering full Phase I-IV services, central labs, and real-world evidence. Broad incumbent that competes with Siron for biotech clinical trial work but at vastly larger scale and with broader therapeutic coverage.

TypeDirect peer
Description

Clinipace is a mid-size CRO serving small to mid-sized biotech with full-service and FSP offerings. Comparable to Siron in target customer segment, FSP/full-service dual model, and therapeutic breadth.

TypeDirect peer
Description

Medpace is a mid-size, full-service CRO that has scaled by serving small and mid-sized biotech sponsors with a full-service model. Comparable to Siron in target customer (small/mid biotech) and clinical trial service offering, though at much larger scale.

TypeDirect peer
Description

Atlantic Research Group is a niche CRO specializing in rare disease, orphan drug, and complex clinical trials. Directly comparable to Siron in rare-disease therapeutic focus and small-biotech customer base.

TypeDirect peer
Description

Ergomed is a UK-headquartered CRO with a particular focus on orphan and rare disease clinical research. Highly comparable to Siron in therapeutic specialization (rare disease), customer base (small/mid biotech), and European operational footprint.

TypeDirect peer
Description

Venn Life Sciences is a European-focused mid-size CRO serving biotech and pharma sponsors. Comparable to Siron in European operational footprint, mid-tier scale, and clinical operations services.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Siron Clinical

Contract Research Organization (CRO) Servicessironclinical.com

Siron Clinical is a Netherlands-based CRO specializing in complex clinical trials for orphan, pediatric, and medical device programs. It serves small and medium-sized biotech sponsors across Europe with customizable FSP and full-service models, and is now part of WEP Clinical following its January 2026 acquisition.

Siron Clinical firmographics

Firmographics
Name
Siron Clinical
Legal name
Siron Clinical
Website
https://sironclinical.com
Company type
Private
Founded year
2000
Operating status
Acquired
Headcount range
11–50 employees
Short description
Siron Clinical is a Netherlands-based CRO specializing in complex clinical trials for orphan, pediatric, and medical device programs. It serves small and medium-sized biotech sponsors across Europe with customizable FSP and full-service models, and is now part of WEP Clinical following its January 2026 acquisition.
Ownership category
akta.pro rank

Siron Clinical industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGAOAA
Clinical Operations & Monitoring FSP (CRA/CTM/Start-up)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Clinical trial services
  • Contract research organization
  • Regulatory submissions
  • Clinical monitoring
  • Orphan disease trials

Where Siron Clinical is headquartered

Location

Headquarters

HQ city
Roosendaal
HQ country
Netherlands
HQ region
Europe

Offices3 records

Markets served

Siron Clinical business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. CRO Services – FSP Engagements: Siron Clinical provides specialized Functional Service Provider engagements where sponsors engage the company for specific tasks and functions (clinical monitoring, regulatory submissions, project management, data management) at every stage of clinical trials. Revenue is generated through service contracts with biotech and pharma sponsors.
  2. CRO Services – Full-Service Contracts: Full-service CRO contracts providing end-to-end clinical trial management from Phase I through Phase IV, covering project management, clinical monitoring, quality assurance, regulatory submissions, and additional services for biotech companies navigating European clinical research.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Siron Clinical product offering

Product offering

Core offering

Siron Clinical is an international contract research organization (CRO) that provides clinical trial services to biotech and biopharma sponsors, including customizable Functional Service Provider (FSP) engagements and full-service CRO contracts. Core offerings cover project management, clinical monitoring, quality assurance and control, regulatory submissions, and additional services such as data management, with specialized expertise in orphan disease, pediatric, and medical device trials across Europe, Israel, and Turkey.

Product overview

Siron Clinical is an international contract research organization (CRO) offering a portfolio of clinical trial services ranging from Customizable Functional Service Provider (FSP) to full-service solutions. The core product offering includes six interconnected service modules: Customizable FSP (providing flexible specialist expertise), Project Management, Clinical Monitoring, Quality Assurance and Control, Regulatory Submissions, and Additional Services (including data management). The company specializes in complex clinical trials across orphan diseases, pediatric research, and medical device sectors, supporting biotech companies through Phase I-IV trial delivery across Europe and the Middle East.

Differentiator

Problem solved

Functional benefit

Products and services

  • Customizable Functional Service Provider (FSP) Flexible outsourcing model providing specialist expertise and fulfilling specific tasks and functions at every stage of clinical trials, allowing biotech sponsors to scale support as needed across functions such as clinical monitoring, regulatory submissions, and project management.
  • Project Management Clinical trial project management and leadership services providing flexibility, innovation, and integrity for successful trial execution for biotech sponsors.
  • Clinical Monitoring Expert monitoring support for investigators and study teams providing strategic knowledge, specific guidance, and expertise for study execution across multiple therapeutic areas, delivered by Siron's senior CRAs.
  • Quality Assurance and Control Quality assurance and quality control services ensuring accuracy and integrity through continual and dynamic quality processes across clinical trial operations.
  • Regulatory Submissions Regulatory submission services with central management of submission processes, handling global regulatory requirements—including the EU Clinical Trials Regulation and CTIS—efficiently and effectively.
  • Additional Services (Data Management and Partnerships) Additional CRO services including clinical data management and industry partnerships for international and regional clinical research support.

Quantifiable outcome

  • 120+ supported clinical studies over 25 years of operation
  • +2 more outcomes

Companies that use Siron Clinical

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles1 record

Siron Clinical technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature2 records

Siron Clinical partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship, core and supporting.

  • WEP ClinicalflagshipStrategic or Co-development Partner · 1 January 2026WEP Clinical, a US-based full-service CRO headquartered in Morrisville, North Carolina, acquired Siron Clinical in January 2026. The acquisition integrates Siron's expertise in orphan diseases, pediatric research, and medical device trials—backed by over 120 supported studies—into WEP's global operations, expanding its Phase I–IV trial delivery capabilities across Europe and the Middle East. Siron continues operating from its current locations in the Netherlands, Belgium, and Germany as part of WEP's Clinical Trials division.
  • MontriumcoreTechnology or Integration · 1 March 2020Siron Clinical partnered with Montrium in March 2020 to provide clients with access to cutting-edge electronic Trial Master File (eTMF) technology. The partnership enables efficient and effective trial documentation management, improved regulatory compliance, and greater inspection readiness. Montrium is an eTMF provider at the forefront of providing electronic solutions to small and medium-sized companies, offering features including document storage, multi-user access, collaboration tools, and version management.
  • Seuss+supportingImplementation/ SI/ Consulting PartnerSiron Clinical partnered with Seuss+, a life-science management consulting company, for its 2020 rebranding from 'Siron' to 'Siron Clinical'. Seuss+ led the brand discovery and creative process, including workshops, visual rebranding, and development of the company's new mission, vision, and values. The rebranding resulted in a new green logo (symbolizing renewal, energy, growth, harmony, and safety) and a modern visual identity reflecting Siron Clinical's DNA.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Siron Clinical competitors and assessment

Company assessment

Broad incumbents

  • ICON plc: ICON is a top-3 global CRO offering full-service and FSP engagements across all therapeutic areas and geographies. Broad incumbent competing with Siron for biotech sponsors seeking full-service or large-FSP partnerships.
  • IQVIA: IQVIA is the largest global CRO offering full Phase I-IV services, central labs, and real-world evidence. Broad incumbent that competes with Siron for biotech clinical trial work but at vastly larger scale and with broader therapeutic coverage.

Direct peers

  • Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-size CRO offering full-service and FSP engagements across multiple therapeutic areas. Comparable to Siron in mid-tier CRO positioning, biotech sponsor focus, and FSP/full-service dual offering.
  • Premier Research: Premier Research is a mid-size CRO with explicit specialization in rare disease, oncology, and pediatric trials. Highly comparable to Siron in niche therapeutic focus and biotech sponsor base.
  • PSI CRO: PSI is a privately held mid-size CRO with strong European roots serving biotech and pharma sponsors across all phases. Comparable to Siron in CRO scale tier, biotech customer focus, and full-service clinical operations.
  • Clinipace Worldwide (now dMed): Clinipace is a mid-size CRO serving small to mid-sized biotech with full-service and FSP offerings. Comparable to Siron in target customer segment, FSP/full-service dual model, and therapeutic breadth.
  • Medpace: Medpace is a mid-size, full-service CRO that has scaled by serving small and mid-sized biotech sponsors with a full-service model. Comparable to Siron in target customer (small/mid biotech) and clinical trial service offering, though at much larger scale.
  • Atlantic Research Group: Atlantic Research Group is a niche CRO specializing in rare disease, orphan drug, and complex clinical trials. Directly comparable to Siron in rare-disease therapeutic focus and small-biotech customer base.
  • Ergomed: Ergomed is a UK-headquartered CRO with a particular focus on orphan and rare disease clinical research. Highly comparable to Siron in therapeutic specialization (rare disease), customer base (small/mid biotech), and European operational footprint.
  • Venn Life Sciences: Venn Life Sciences is a European-focused mid-size CRO serving biotech and pharma sponsors. Comparable to Siron in European operational footprint, mid-tier scale, and clinical operations services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Siron Clinical social profiles

Digital presence

Siron Clinical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Siron Clinical leadership team

Management profile

Number of profiles

Profiles1 record

Siron Clinical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Siron Clinical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Siron Clinical

What does Siron Clinical do?

Siron Clinical is an international contract research organization (CRO) that provides clinical trial services to biotech and biopharma sponsors, including customizable Functional Service Provider (FSP) engagements and full-service CRO contracts. Core offerings cover project management, clinical monitoring, quality assurance and control, regulatory submissions, and additional services such as data management, with specialized expertise in orphan disease, pediatric, and medical device trials across Europe, Israel, and Turkey.

Is Siron Clinical a public or private company?

Siron Clinical is a private company. It is classified as corporate owned and is currently acquired.

When was Siron Clinical founded?

Siron Clinical was founded in 2000. It employs 11 to 50 people.

Where is Siron Clinical based?

Siron Clinical is headquartered in Roosendaal, Netherlands, in the Europe region.

How does Siron Clinical make money?

Two revenue lines are on record. CRO Services – FSP Engagements are the primary driver. The others are CRO Services – Full-Service Contracts.

Who are Siron Clinical's main competitors?

Broad incumbents on record are ICON plc and IQVIA. Direct peers are Worldwide Clinical Trials, Premier Research, PSI CRO, Clinipace Worldwide (now dMed), Medpace, Atlantic Research Group, Ergomed and Venn Life Sciences.

Does Siron Clinical have an API?

No public API is recorded for Siron Clinical.

What industry is Siron Clinical in?

Siron Clinical's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
InvestorsinhealthcareNetherlands: WEP Clinical expands global footprint with acquisition of Siron ClinicalUS-based WEP Clinical has acquired Netherlands-based Siron Clinical, a CRO services provider operating across Europe, Israel, and Turkey, expanding WEP's global footprint in clinical trial services. The acquisition combines WEP's global infrastructure with Siron's operational expertise in complex, rare, and specialized therapeutic areas, including orphan diseases, pediatric research, and medical device trials. Both companies state the combined entity will offer more robust and scalable solutions for biotech sponsors worldwide.Business Wire IndiaWEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I–IV Trial Delivery CapabilitiesWEP Clinical, a US-based full-service CRO, has acquired Siron Clinical, a Netherlands-based European CRO specializing in complex clinical operations for biotech companies. The acquisition, whose financial terms were not disclosed, expands WEP's global footprint and integrates Siron's expertise in orphan diseases, pediatric research, and medical device trials into WEP's existing clinical trials division. Siron will continue operating from its current locations in the Netherlands, Belgium, and Germany, with its team of clinical research professionals across Europe and the Middle East joining WEP.AETOSWireWEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I–IV Trial Delivery CapabilitiesWEP Clinical acquired Siron Clinical, a Netherlands-based CRO, to expand its global Phase I-IV trial delivery capabilities. Siron, founded in 2000, has supported over 120 studies and will integrate into WEP's Clinical Trials division. The deal aims to offer sponsors seamless support from early-phase development through post-approval research.PharmiWeb.comWEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I–IV Trial Delivery CapabilitiesWEP Clinical, a US-based full-service CRO headquartered in Morrisville, North Carolina, announced the acquisition of Netherlands-based Siron Clinical, a European CRO specializing in complex clinical operations for biotech companies. The acquisition integrates Siron's expertise in orphan diseases, pediatric research, and medical device trials—backed by over 120 supported studies—into WEP's global operations, expanding its Phase I–IV trial delivery capabilities across Europe and the Middle East. Siron, founded in 2000 with offices in Belgium and Germany, will be incorporated into WEP's Clinical Trials division, providing clients access to a larger pool of experienced CRAs, project managers, and operational leaders alongside WEP's broader treatment access and commercialization offerings.FierceBiotechWEP Clinical grabs European CRO Siron Clinical, broadening global capabilitiesNorth Carolina-based CRO WEP Clinical announced the acquisition of European CRO Siron Clinical on January 5, with financial terms not disclosed. Siron, headquartered in the Netherlands, brings expertise in orphan diseases, pediatric research, and medical device trials, having supported more than 120 studies. The deal enables WEP to offer end-to-end clinical trial solutions from phase 1 to phase 4 across rare and specialized therapeutic areas, with Siron staff and offices in Belgium and Germany falling under WEP's clinical trials division.WepclinicalWEP CLINICAL ACQUIRES NETHERLANDS-BASED CRO SIRON CLINICAL, EXPANDING GLOBAL PHASE I–IV TRIAL DELIVERY CAPABILITIESWEP Clinical acquired Netherlands-based CRO Siron Clinical, expanding its global Phase I–IV trial delivery capabilities. Siron, founded in 2000, has supported over 120 studies and will be integrated into WEP's Clinical Trials division. The acquisition aims to strengthen support for complex, rare, and specialized therapeutic areas.BioSpaceWEP Clinical Acquires Netherlands-Based CRO Siron Clinical, Expanding Global Phase I–IV Trial Delivery CapabilitiesWEP Clinical, a US- and UK-based contract research organization, has acquired Netherlands-based Siron Clinical, a European CRO specializing in complex clinical operations for biotech companies. The acquisition integrates Siron's expertise in orphan diseases, pediatric research, and medical device trials—along with its 120+ supported studies and teams across Europe and the Middle East—into WEP's global operations. Siron will become part of WEP's Clinical Trials division, expanding its end-to-end Phase I–IV trial delivery capabilities in rare and specialized therapeutic areas.SironclinicalClinical trial success depends on strong partnerships – here’s whyThe article outlines the strategic importance of collaboration in clinical trials, highlighting benefits such as access to specialized expertise, increased operational agility, and improved patient recruitment. It identifies key partners including Contract Research Organizations (CROs), clinical sites, regulators, and patient groups as essential for trial success. The piece concludes with best practices for managing these partnerships, drawn from the author's experience at Siron Clinical.SironclinicalHow small biotech can overcome clinical trial hurdlesThis article provides guidance on challenges facing small biotech companies in clinical development, including budget constraints (contributing to 22% of failed phase III trials), complex regulatory requirements, resource and expertise gaps, and participant recruitment difficulties (with only 31% of UK clinical trials meeting enrollment goals). It emphasizes that small biotech companies, responsible for 67% of FDA approvals in 2020 focused on niche indications, can overcome these hurdles through strategic partnerships with CROs and service providers operating on a Flexible Service Provider basis. The article presents Siron Clinical as a solution provider offering expertise across the clinical trials process.